XML 38 R31.htm IDEA: XBRL DOCUMENT
v3.25.3

Financial Instruments (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Information Related to Recurring Fair Value Measurement of Derivative Instruments in Our Consolidated Condensed Balance Sheet | Information related to the recurring fair value measurement of derivative instruments in the consolidated condensed balance sheet as of September 30, 2025 is as follows:
|  |  |  |  |  |  | Asset Derivatives |  |  | Liability Derivatives |  |  |  |
|  | Fair Value Hierarchy |  | Notional Amount |  |  | Balance Sheet Location |  | Fair Value |  |  | Balance Sheet Location |  | Fair Value |  |  | Net Assets/ (Liabilities) |
Derivatives Designated as Cash Flow Hedges |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency derivatives |  | Level 2 |  | $ | 80,649 |  |  | Other current assets |  | $ | 5,870 |  |  | Other current liabilities |  | $ | — |  |  | $ | 5,870 |
Interest rate contracts |  | Level 2 |  | $ | 100,000 |  |  | Other current assets |  | $ | — |  |  | Other current liabilities |  | $ | 757 |  |  | $ | (757 | )
Information related to the recurring fair value measurement of derivative instruments in the consolidated condensed balance sheet as of December 31, 2024 is as follows:
|  |  |  |  |  |  | Asset Derivatives |  |  | Liability Derivatives |  |  |  |
|  | Fair Value Hierarchy |  | Notional Amount |  |  | Balance Sheet Location |  | Fair Value |  |  | Balance Sheet Location |  | Fair Value |  |  | Net Assets/ (Liabilities) |
Derivatives Designated as Cash Flow Hedges |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency derivatives |  | Level 2 |  | $ | 126,496 |  |  | Other current assets |  | $ | — |  |  | Other current liabilities |  | $ | 2,037 |  |  | $ | (2,037 | )
Derivatives Not Designated as Hedging Instruments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate contracts |  | Level 2 |  | $ | 100,000 |  |  | Other current assets |  | $ | 719 |  |  | Other current liabilities |  | $ | — |  |  | $ | 719 |
Information Related to Effect of Derivative Instruments on Our Consolidated Condensed Statements of income and Consolidated Condensed Statements of Comprehensive Income | Information relating to the effect of derivative instruments on the consolidated condensed statements of income and the consolidated condensed statements of comprehensive income is as follows:
|  |  |  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | Location (Income/(Loss)) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Derivatives Designated as Cash Flow Hedges |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency derivatives |  | Cost of sales – income (loss) |  | $ | 2,086 |  |  | $ | (455 | ) |  | $ | 273 |  |  | $ | 5,817 |
|  | Other comprehensive income (loss) |  |  | 91 |  |  |  | (2,272 | ) |  |  | 9,844 |  |  |  | (10,685 | )
Total foreign currency derivatives |  |  |  | $ | 2,177 |  |  | $ | (2,727 | ) |  | $ | 10,117 |  |  | $ | (4,868 | )
Interest rate contracts |  | Interest expense, net |  | $ | 156 |  |  | $ | — |  |  | $ | 156 |  |  | $ | — |
|  | Other comprehensive income (loss) |  |  | (58 | ) |  |  | — |  |  |  | (757 | ) |  |  | — |
Total interest rate derivatives |  |  |  | $ | 98 |  |  | $ | — |  |  | $ | (601 | ) |  | $ | — |
Derivatives Not Designated as Hedging Instruments |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate contracts |  | Interest expense, net |  | $ | (104 | ) |  | $ | (1,157 | ) |  | $ | (719 | ) |  | $ | (1,161 | )
Total interest rate derivatives |  |  |  | $ | (104 | ) |  | $ | (1,157 | ) |  | $ | (719 | ) |  | $ | (1,161 | )
Summary of Receivables Factored and Availability Under Receivables Factoring Agreements | Receivables factored under receivables factoring agreements balance as of December 31, 2024 were as follows:
|  | December 31, 2024 |
Receivables factored and outstanding |  | $ | 755 |
Summary of Trade Receivables Sold and Factoring Fees Incurred | Trade receivables sold and factoring fees incurred during the three and nine months ended September 30, 2024 were as follows:
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2024 |  |  | 2024 |
Trade receivables sold |  | $ | 27,885 |  |  | $ | 98,761 |
Factoring fees incurred |  |  | 186 |  |  |  | 564 |

X
- Definition Summary of receivables factored and availability under receivables factoring agreements. + References No definition available. + Details
Name: | thrm_SummaryOfReceivablesFactoredAndAvailabilityUnderReceivablesFactoringAgreementsTableTextBlock
Namespace Prefix: | thrm_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Summary of trade receivables sold and factoring fees incurred. + References No definition available. + Details
Name: | thrm_SummaryOfTradeReceivablesSoldAndFactoringFeesIncurredTableTextBlock
Namespace Prefix: | thrm_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4CC -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CC Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C + Details
Name: | us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration